Literature DB >> 21358299

Screening colonoscopy among colorectal cancer survivors insured by Medicaid.

Kristie Long Foley1, Eun-Young Song, Heidi Klepin, Ann Geiger, Janet Tooze.   

Abstract

OBJECTIVES: The objectives of this research study are to describe the proportion of Medicaid-insured colorectal cancer survivors who had a colonoscopy between 3 and 18 months after surgery of the colon or rectum and to determine if patient, health services, and community characteristics are associated with colonoscopy follow-up after treatment.
METHODS: A retrospective cohort study among 1044 Medicaid-insured individuals diagnosed with local or regional colorectal cancer was conducted. Multivariable logistic regression analyses assessed patient, hospital, and community characteristics associated with colonoscopy.
RESULTS: About 42% of the study population had a colonoscopy 3 to 18 months after surgery. Factors associated with receipt of colonoscopy in the multivariable model include having colon (vs rectal) cancer, having local (vs regional) cancer, and having received chemotherapy as part of first course of therapy. Being 75 or older (vs <65), having first course of therapy at a hospital with the highest surgical volume (vs lowest surgical volume), and living in an urban (vs rural) environment were associated with a decreased likelihood of colonoscopy. Colonoscopy utilization patterns diverge after 65 years of age when persons become dually insured by Medicare. By age 80 years, there seems to be an almost 3-fold difference in receipt of colonoscopy-those with comorbidity are more likely to be screened than those without comorbidity.
CONCLUSIONS: Less than half of Medicaid-insured colorectal cancer survivors received a colonoscopy in 3 to 18 months after colorectal resection. Improvements in screening in this high-risk population should be the target of future interventions to reduce the probability of recurrence.

Entities:  

Mesh:

Year:  2012        PMID: 21358299      PMCID: PMC4589146          DOI: 10.1097/COC.0b013e318209d21e

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  31 in total

Review 1.  Racial and ethnic disparities in the receipt of cancer treatment.

Authors:  Vickie L Shavers; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

2.  Data sources for measuring colorectal endoscopy use among Medicare enrollees.

Authors:  Anna P Schenck; Carrie N Klabunde; Joan L Warren; Sharon Peacock; William W Davis; Sarah T Hawley; Michael Pignone; David F Ransohoff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-10       Impact factor: 4.254

3.  Insurance status and the use of guideline therapy in the treatment of selected cancers.

Authors:  Linda C Harlan; Amanda L Greene; Limin X Clegg; Margaret Mooney; Jennifer L Stevens; Martin L Brown
Journal:  J Clin Oncol       Date:  2005-11-21       Impact factor: 44.544

4.  Disparities in cancer diagnosis and survival.

Authors:  C J Bradley; C W Given; C Roberts
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

5.  Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States.

Authors:  Talya Salz; Morris Weinberger; John Z Ayanian; Noel T Brewer; Craig C Earle; Jennifer Elston Lafata; Deborah A Fisher; Bryan J Weiner; Robert S Sandler
Journal:  BMC Health Serv Res       Date:  2010-09-01       Impact factor: 2.655

6.  Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery.

Authors:  Gary L Ellison; Joan L Warren; Kevin B Knopf; Martin L Brown
Journal:  Health Serv Res       Date:  2003-12       Impact factor: 3.402

7.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

8.  A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States).

Authors:  Selwyn O Rogers; Wayne A Ray; Walter E Smalley
Journal:  Cancer Causes Control       Date:  2004-03       Impact factor: 2.506

9.  Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum.

Authors:  Juliet VanEenwyk; Joseph S Campo; Eric M Ossiander
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

10.  Treatment differences between blacks and whites with colorectal cancer.

Authors:  J K Ball; A Elixhauser
Journal:  Med Care       Date:  1996-09       Impact factor: 2.983

View more
  2 in total

1.  Are cancer registries a viable tool for cancer survivor outreach? A feasibility study.

Authors:  Melissa Y Carpentier; Jasmin A Tiro; Lara S Savas; L Kay Bartholomew; Trisha V Melhado; Sharon P Coan; Keith E Argenbright; Sally W Vernon
Journal:  J Cancer Surviv       Date:  2012-12-18       Impact factor: 4.442

Review 2.  Receipt of recommended surveillance among colorectal cancer survivors: a systematic review.

Authors:  Melissa Y Carpentier; Sally W Vernon; L Kay Bartholomew; Caitlin C Murphy; Shirley M Bluethmann
Journal:  J Cancer Surviv       Date:  2013-05-16       Impact factor: 4.442

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.